 Pasithea Therapeutics KTTA , Financial KTTAW , Financial caught my eye recently as an emerging biotech player with a different approach to business. On first impression, the company may seem like any other listed development-stage biotechnology player which could take years to generate any kind of revenues and which will go through a string of public issues to finance its research, resulting in constant dilution. 